BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7386280)

  • 1. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 16-p-fluorophenoxy prostanoid with potent and long-lasting thromboxane-like actions [proceedings].
    Jones RL; Wilson NH
    Br J Pharmacol; 1978 Jun; 63(2):362P. PubMed ID: 667444
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
    Patscheke H; Stegmeier K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
    [No Abstract]   [Full Text] [Related]  

  • 7. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.
    Pollock WK; Armstrong RA; Brydon LJ; Jones RL; MacIntyre DE
    Biochem J; 1984 May; 219(3):833-42. PubMed ID: 6234886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
    Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
    J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H2 directly lowers human platelet cAMP levels.
    Rybicki JP; Le Breton GC
    Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
    Samuelsson B
    Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 13. [The antithromboxane activity of alpha- and omega-modified carbocyclic analogs of PGH1].
    Kuz'mitskiĭ BB; Bondar' NF; Malaeva LP
    Eksp Klin Farmakol; 1992; 55(4):31-3. PubMed ID: 1458183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure of the platelet aggregation factor thromboxane A2.
    Bhagwat SS; Hamann PR; Still WC; Bunting S; Fitzpatrick FA
    Nature; 1985 Jun 6-12; 315(6019):511-3. PubMed ID: 4000279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of prostaglandin F2 alpha from prostaglandins H2 and D2 by an apparently homogeneous enzyme.
    Watanabe K; Yoshida R; Shimizu T; Hayaishi O
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():151-3. PubMed ID: 2936081
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
    Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
    Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of human lymph contractility by prostaglandins and thromboxane.
    Sinzinger H; Kaliman J; Mannheimer E
    Lymphology; 1984 Jun; 17(2):43-5. PubMed ID: 6381904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboxane A2-like activity of 11-fluoro-11-deoxyprostaglandin F2alpha in isolated smooth muscles].
    Nigamatov IM; Serkov IV; Gafurov RG; Bezuglov VV; Bergel'son LD
    Dokl Akad Nauk SSSR; 1986; 288(2):507-9. PubMed ID: 3720506
    [No Abstract]   [Full Text] [Related]  

  • 19. Action and metabolism of prostaglandins in the pulmonary circulation.
    Kadowitz PJ; Lippton HL; McNamara DB; Spannhake EW; Hyman AL
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():333-56. PubMed ID: 6216787
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of prostaglandin H2 on perinatal pulmonary circulation.
    Tod ML; Cassin S; McNamara DB; Kadowitz PJ
    Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.